Filter your results
- 3
- 1
- 4
- 4
- 1
- 1
- 1
- 1
- 4
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 4
- 3
- 3
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
4 Results
|
|
sorted by
|
|
Anti-MDA5 juvenile idiopathic inflammatory myopathy: a specific subgroup defined by differentially enhanced interferon-α signallingRheumatology, 2020, 59 (8), pp.1927-1937. ⟨10.1093/rheumatology/kez525⟩
Journal articles
pasteur-02383120v1
|
||
|
Exploring necrotizing autoimmune myopathies with a novel immunoassay for anti-3-hydroxy-3-methyl-glutaryl-CoA reductase autoantibodies.Arthritis Research and Therapy, 2014, 16 (1), pp.R39. ⟨10.1186/ar4468⟩
Journal articles
inserm-00950634v1
|
||
|
Antisynthetase syndrome positive for anti-threonyl-tRNA synthetase (anti-PL7) antibodies.European Respiratory Journal, 2011, 37 (3), pp.714-7. ⟨10.1183/09031936.00104310⟩
Journal articles
hal-00873290v1
|
||
Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center studyAutoimmunity Reviews, 2016, 15 (10), pp.983-993. ⟨10.1016/j.autrev.2016.07.023⟩
Journal articles
hal-02377492v1
|